Pacira BioSciences, Inc.

PCRX Nasdaq SEC CIK 1396814
Follow Pacira BioSciences Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $176.7M −1.6% vs same quarter last year
Net income $28.5M +425.1% vs same quarter last year
EPS, diluted $0.70 +483.3% vs same quarter last year
Operating cash flow $50.1M −17.7% vs same quarter last year
Revenue by quarter
$187.3M
$168.9M
$181.1M
$179.5M
$196.9M
$177.4M
$192.4M
$176.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$250M$0$250M$500M$750MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$726.4M$7M
FY24$701M−$99.6M
FY23$675M$42M
FY22$666.8M$15.9M
FY21$541.5M$42M
FY20$429.6M$145.5M
FY19$418.9M−$11M
FY18$332.4M−$471K
FY17$284.3M−$42.6M
FY16$270.1M−$37.9M
FY15$249M$1.9M
FY14$197.7M−$13.7M
FY13$85.6M−$63.9M
FY12$39.1M−$52.3M
FY11$15.7M−$43.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−300%−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2579.4%2.6%1%
FY2475.7%−10.5%−14.2%
FY2372.6%13%6.2%
FY2270.1%9%2.4%
FY2174.1%16.6%7.8%
FY2072.7%10.8%33.9%
FY1974.5%2.5%−2.6%
FY1873.9%4.8%−0.1%
FY1769.1%−8.8%−15%
FY1659.2%−11.9%−14.1%
FY1571.1%3.8%0.7%
FY1460.8%−2.6%−6.9%
FY1336%−62.3%−74.7%
FY1217.8%−126.1%−133.8%
FY11−6.7%−249.2%−276.2%
Free cash flowOperating cash flow minus capital expenditure
−$100M$0$100M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$136.7M
FY24$178.8M
FY23$139.5M
FY22$115.2M
FY21$79.9M
FY20$39.2M
FY19$60.4M
FY18$34.4M
FY17−$1.5M
FY16$8.7M
FY15−$12.3M
FY14$3.6M
FY13−$56M
FY12−$88.4M
FY11−$37.2M
Returned to shareholdersDividends paid and shares bought back
$0$50M$100M$150MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$148.3M
FY24$25M
FY23$0
FY22$0
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Pacira BioSciences
  • Healthcare median
−300%−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPacira BioSciencesHealthcare median
FY251%−30.6%
FY24−14.2%−47%
FY236.2%−58%
FY222.4%−80.4%
FY217.8%−71.8%
FY2033.9%−62.2%
FY19−2.6%−46.2%
FY18−0.1%−49.6%
FY17−15%−45.9%
FY16−14.1%−36%
FY150.7%−37.8%
FY14−6.9%−35.5%
FY13−74.7%−37.1%
FY12−133.8%−29.1%
FY11−276.2%−27.9%